PF-04479745
Chemical compound
From Wikipedia, the free encyclopedia
PF-04479745 is a research ligand developed by Pfizer.[1] It is related to lorcaserin, and acts as a potent and selective agonist for the 5-HT2C receptor, with lower affinity and antagonist action at the related 5-HT2A and 5-HT2B receptor subtypes.[2]
Other namesPF04479745; PF-4479745; PF4479745
Drug classSerotonin 5-HT2C receptor biased agonist; Serotonin 5-HT2A receptor antagonist; Serotonin 5-HT2B receptor antagonist
ATC code
- None
Legal status
- In general: uncontrolled
| Clinical data | |
|---|---|
| Other names | PF04479745; PF-4479745; PF4479745 |
| Drug class | Serotonin 5-HT2C receptor biased agonist; Serotonin 5-HT2A receptor antagonist; Serotonin 5-HT2B receptor antagonist |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C17H22N4 |
| Molar mass | 282.391 g·mol−1 |
| 3D model (JSmol) | |
| |
| |